The objective of the retrospective cohort study was to describe immediate and long-term results of carotid endarterectomy (cea) versus carotid stenting (cas) with embolic protection in patients with severe carotid artery stenosis in clinical practice.The study covered 2132 operations in 2006 patients with 57% of these being carotid endarterectomies (cea) and 43% carotid artery stents (cas).All cas procedures were performed under local anaesthesia.Routine embolic protection and dual antiplatelet therapy were used in all cases.The primary endpoint was any stroke, death or myocardial infarction (mi) during the 30-day period post procedure.No device malfunctions, or intr-operative complications are reported.278 patients were lost to follow-up.Of the cas group, 47.6% of patient¿s were treated with medtronic¿s protégé rx carotid stent system.Embolic protection was used in all cases, with 82.6% of patients being treated with a spider fx embolic protection device, and 7% with a moma cerebral protection device.Within the cas group, during the 30-day follow-up period, the following complications are reported: death, stroke, transient ischemic attack (tias), cranial and cervical nerve injuries, and bleeding.Within the 5-year post-procedural follow-up, complications of death, stroke, myocardial infarction(mi), and transient ischemic attack (tias) are reported.The deaths that occurred during the 5-year follow-up were attributed to myocardial infarction, stroke and oncological causes.
|